A novel antihypertensive agent: 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline.
D000284:Administration, Oral; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002415:Cats; D004285:Dogs; D007093:Imidazoles / Q000138:chemical synthesis / Q000494:pharmacology; D008722:Methods; D011799:Quinazolines / Q000138:chemical synthesis* / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology
D000959:Antihypertensive Agents; D007093:Imidazoles; D011799:Quinazolines; D013565:Sympatholytics; C003408:1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline